• Managing Rheumatic Conditions in Pregnancy Dr Kevin Deane reviews new data on treatment outcomes during pregnancy in women with autoimmune diseases.
  • 2017 Advances in Rheumatology Dr Kevin Deane reviews new trials, new treatments, and other major breakthroughs in rheumatology over the past year.
  • Toward Earlier Identification of Rheumatic Diseases Dr Kevin Deane reviews two new studies that offer simple approaches to improve early recognition of RA and SLE in primary care.
  • Identifying Preclinical Psoriatic Arthritis in Hope of Prevention Dr Kevin Deane explains how this new research may provide a window of opportunity for preventing psoriatic arthritis.
  • Diet and Risk for Rheumatoid Arthritis Dr Kevin Deane highlights a new study exploring how a healthy diet can influence the risk of developing rheumatoid arthritis.
  • White Blood Cells Can Predict Steroid Response in OA Dr Kevin Deane highlights a study showing that higher synovial fluid white blood cell counts are associated with improved pain after methylprednisolone injection.
  • Getting Your RA Patients to Stop Smoking Dr Kevin Deane looks at a new study comparing separate methods for getting patients with RA to give up cigarettes for good.
  • 10 Rheumatology Advances From 2016 Dr Kevin Deane reviews new trials, new treatments, and other major breakthroughs in rheumatology over the past year.
  • In RA, When to Stop Anti-TNF Therapy Dr Kevin Deane discusses a new study assessing whether patients in remission or with stable low disease activity could safely stop therapy.
  • A Promising Treatment for Polymyalgia Rheumatica Dr Kevin Deane highlights the latest data with this therapy and what it might mean for both polymyalgia rheumatica and giant-cell arteritis.
  • Obesity, OA, and the Need for Knee Replacement Dr Deane reviews and discusses a study that looks at the relationship between increasing body mass index and knee replacement among patients with osteoarthritis.
  • Biologics: An Important Piece of Patient Advice Dr Deane reviews and discusses a study finding that the majority of patients receiving a biologic drug for their rheumatic disease did not store it at the correct temperature.
  • How Should We Define Sacroiliitis? Dr Deane reviews a study that evaluated the Assessment of SpondyloArthritis international Society (ASAS) in a cohort of patients with persistent low back pain.
  • Should RA Diagnostic Cut-off Points Be Lowered? Dr Deane reviews the results of a study evaluating different cut-off points for scores to diagnose rheumatoid arthritis with the 2010 ACR/EULAR criteria.
  • Sustaining Remission After RA Therapy Ends Dr Deane discusses results from a randomized trial evaluating maintenance of remission after rapid withdrawal of abatacept and methotrexate--alone or in combination.
  • In Those With Psoriasis, Treat for Arthritis? Dr Deane reviews the results of a study that identified and followed patients with cutaneous psoriasis to determine their risk of developing inflammatory arthritis.
  • Casting a 'NET' to Find New Therapies for Lupus Dr Deane discusses a study that first examined the role of neutrophil extracellular traps in lupus pathophysiology, and then evaluated metformin to reduce disease flares in a proof-of-concept trial.
  • The Link Between Sleep Apnea and Gout Dr Deane discusses a recent study that found an association between incident gout and sleep apnea, providing further evidence for a link between cardiopulmonary physiology and hyperuricemia.
  • Rheumatology Advances to Know From 2015 Dr Kevin Deane looks back at the biggest advances in rheumatology in 2015.
  • Visual Outcomes in Idiopathic Intracranial Hypertension A new study looks at risk factors for poor visual outcome in patients with idiopathic intracranial hypertension.
learn more